Skip to main content

Rockefeller Capital Management L.P.

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1739439 NEW YORK, NY

Position in RXRX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$802,844
+$662,602 QoQ
Shares Held
261,513
+662.7% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rockefeller Capital Management L.P. holds $285,800,136 across 243 Biotechnology names. RXRX ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $802,844 261,513
2025-12-31 $140,242 34,289
2025-09-30 $260,757 53,434
2025-06-30 $1,096,829 216,765
2025-03-31 $2,049,641 387,456
2024-12-31 $1,905,792 281,922
2024-09-30 $439,151 66,639
2024-03-31 $211,822 21,246
2022-12-31 $18,334 2,378
2022-09-30 $77,874 7,319
2022-06-30 $48,359 5,941
2022-03-31 $90,130 12,588
2021-12-31 $178,100 10,397
2021-09-30 $47,170 2,050
2021-06-30 $36,500 1,000